Ana Cristina SILVA-PINTO Incidence of vaso-occlusive crises in patients with sickle cell disease (SCD) and a high baseline disease burden treated with crizanlizumab in a real-world setting: Results from a managed access program (MAP) Thursday, June 16th 19:20 - 19:35 UTC+2 View all speakers
